Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)”

Opioid use disorder continues to be a significant problem in the United States and worldwide. Three medications—methadone, buprenorphine, and extended-release injectable naltrexone,— are efficacious for treating opioid use disorder (OUD). However, the utility of these medications is limited, in part...

Descripción completa

Detalles Bibliográficos
Autores principales: Shulman, Matisyahu, Weiss, Roger, Rotrosen, John, Novo, Patricia, Costello, Elizabeth, Nunes, Edward V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936466/
https://www.ncbi.nlm.nih.gov/pubmed/33676577
http://dx.doi.org/10.1186/s13722-021-00223-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936466/
https://www.ncbi.nlm.nih.gov/pubmed/33676577
http://dx.doi.org/10.1186/s13722-021-00223-z

Ejemplares similares